Aleksandra Simiczyjew

Department of Cell Pathology, University of Wroclaw

Research Area

Biography

Aleksandra Simiczyjew has not added Biography.
If you are Aleksandra Simiczyjew and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
[Functional diversification of cytoplasmic actin isoforms]. Postepy biochemii\| PubMed ID: 24364211	2013
Effect of overexpression of β- and γ-actin isoforms on actin cytoskeleton organization and migration of human colon cancer cells. Histochemistry and cell biology\| PubMed ID: 24682235	2014
Active invadopodia of mesenchymally migrating cancer cells contain both β and γ cytoplasmic actin isoforms. Experimental cell research\| PubMed ID: 26548725	2015
An end-to-end software solution for the analysis of high-throughput single-cell migration data. Scientific reports\| PubMed ID: 28205527	2017
Involvement of β- and γ-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells. PloS one\| PubMed ID: 28333953	2017
Are non-muscle actin isoforms functionally equivalent? Histology and histopathology\| PubMed ID: 28439872	2017
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. PloS one\| PubMed ID: 29304116	2018
Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines. Oncotarget\| PubMed ID: 29719603	2018
Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines. Cancers\| PubMed ID: 30227653	2018
Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells. Journal of cellular and molecular medicine\| PubMed ID: 31638339	2019
Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities. Frontiers in pharmacology\| PubMed ID: 31649529	2019
Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment. International journal of molecular sciences\| PubMed ID: 31877948	2019
The Influence of Tumor Microenvironment on Immune Escape of Melanoma. International journal of molecular sciences\| PubMed ID: 33171792	2020
Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy. International journal of molecular sciences\| PubMed ID: 33430277	2021
PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study. Cells\| PubMed ID: 33572647	2021
A Fluorescent Gelatin Degradation Assay to Study Melanoma Breakdown of Extracellular Matrix. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 33704704	2021
Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance. Cells\| PubMed ID: 33918883	2021
Alpha-Enolase (ENO1) Correlates with Invasiveness of Cutaneous Melanoma-An In Vitro and a Clinical Study. Diagnostics (Basel, Switzerland)\| PubMed ID: 35204345	2022
Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts. Cell communication and signaling : CCS\| PubMed ID: 35538545	2022
Melanoma stimulates the proteolytic activity of HaCaT keratinocytes. Cell communication and signaling : CCS\| PubMed ID: 36123693	2022
Novel hybrid composites based on double-decker silsesquioxanes functionalized by methacrylate derivatives and polyvinyl alcohol as potential materials utilized in biomedical applications. Biomaterials advances\| PubMed ID: 36682203	2023
Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche. Cellular & molecular biology letters\| PubMed ID: 37481560	2023
The impact of cellular elements of TME on melanoma biology and its sensitivity to EGFR and MET targeted therapy. Biochimica et biophysica acta. Molecular cell research\| PubMed ID: 37506884	2023
Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells. Journal of cellular and molecular medicine\| PubMed ID: 37679999	2023
Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib). Cell communication and signaling : CCS\| PubMed ID: 39175042	2024
Response of Primary Human Adipocytes to Fatty Acid Treatment. Journal of cellular and molecular medicine\| PubMed ID: 40418213	2025
Phenotype switching in highly invasive resistant to vemurafenib and cobimetinib melanoma cells. Cell communication and signaling : CCS\| PubMed ID: 41121376	2025
Stromal cells as a part of tumor microenvironment of melanoma: Their role in cancer progression and drug resistance. Advances in clinical and experimental medicine : official organ Wroclaw Medical University\| PubMed ID: 41194437	2025
Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells. Journal of proteome research\| PubMed ID: 41742019	2026
Comprehensive transcriptomic characterization of two melanoma cell lines with acquired dual resistance to BRAF and MEK inhibitors. Scientific reports\| PubMed ID: 41872271	2026